120
Participants
Start Date
April 26, 2021
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
Cardiac and Brain MRI
"A CMR to evaluate for LA and LAA high-risk features on either a 1.5 or 3 Tesla clinical MR scanner will be used. Gadolinium injection will be administered. Gadolinium is a contrast product that helps define areas of fibrosis in the LA.~High-resolution brain MRI with no contrast will include the following sequences for most accurate assessment of embolic lesions: 3D T1 MPRAGE, 3D FLAIR, DWI, ADC, and SWI"
RECRUITING
Tulane University Medical Center, New Orleans
Tulane University
OTHER